2m 2m 2m 2m 2m 2m 2m
Zimmer Biomet Hldgs (ZBH)
NYSE
$87.58+$0.49 (+0.56%)
Price as of Jun 23, 2026 6:07 PM EDT- $16.8BMarket Cap
- -3.82%1-Year Change
- Medical DevicesIndustry
Zimmer Biomet Hldgs (ZBH)
$87.58+$0.49 (+0.56%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 8.2B +7.20% | 7.7B +3.85% | 7.4B +6.55% | 6.9B -11.44% | |
Cost of Revenue | 2.5B +13.81% | 2.2B +5.15% | 2.1B +3.18% | 2.0B -13.73% | |
Gross Profit | 5.7B +4.56% | 5.5B +3.33% | 5.3B +7.93% | 4.9B -10.46% | |
Sales and Marketing Expense | 3.3B +11.17% | 2.9B +3.20% | 2.8B +2.80% | 2.8B -16.91% | |
Research and Development Expense | -458.5M +4.82% | -437.4M -4.64% | -458.7M +12.98% | -406.0M -18.34% | |
Depreciation and Amortization Expense | 1.1B +9.79% | 996.3M +4.69% | 951.7M +2.73% | 926.4M -13.21% | |
Total Operating Expenses | 7.1B +11.58% | 6.4B +4.52% | 6.1B -2.04% | 6.2B -11.51% | |
Operating Profit | 1.1B -14.59% | 1.3B +0.63% | 1.3B +83.50% | 696.3M -10.74% | |
Interest Income | 14.7M N/A | 0 -100.00% | 2.5M +102.14% | -116.6M N/A | |
Interest Expense | -292.8M +34.31% | -218.0M +8.35% | -201.2M +22.09% | -164.8M -20.92% | |
Interest Income and Expense and Net | -278.1M +27.57% | -218.0M +9.71% | -198.7M -29.39% | -281.4M +35.03% | |
Total Nonoperating Income and Expense | 25.5M +181.99% | -31.1M +234.41% | -9.3M -92.73% | -128.0M -1,184.75% | |
Income before Taxes | 830.8M -19.85% | 1.0B -2.88% | 1.1B +164.51% | 403.5M -3.56% | |
Income Taxes | 125.7M -4.34% | 131.4M +211.37% | 42.2M -62.42% | 112.3M +588.96% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 705.1M -21.98% | 903.8M -11.74% | 1.0B +342.52% | 231.4M -42.38% | |
Net Income from Continuing Operations Applicable to Common | 830.8M -8.08% | 903.8M -11.74% | 1.0B +252.86% | 290.2M -30.64% | |
Basic EPS and Net Income | 3.56 -20.00% | 4.45 -9.37% | 4.91 +346.36% | 1.10 -43.01% | |
Diluted EPS and Net Income | 3.55 -19.86% | 4.43 -9.22% | 4.88 +343.64% | 1.10 -42.41% | |
Basic Weighted Average Shares | 198.0M -2.51% | 203.1M -2.68% | 208.7M -0.43% | 209.6M +0.48% | |
Diluted Weighted Average Shares | 198.7M -2.55% | 203.9M -2.77% | 209.7M -0.29% | 210.3M -0.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 591.9M +12.64% | 525.5M +26.38% | 415.8M +10.67% | 375.7M -21.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 591.9M +12.64% | 525.5M +26.38% | 415.8M +10.67% | 375.7M -21.48% | |
Total Current Assets | 5.1B +9.60% | 4.7B +1.35% | 4.6B +4.12% | 4.4B -9.37% | |
Accumulated Depreciation | 5.1B +8.81% | 4.6B -1.37% | 4.7B +2.61% | 4.6B -2.82% | |
Property and Plant and Equipment and Net | 2.2B +7.73% | 2.0B -0.56% | 2.1B +10.03% | 1.9B -7.14% | |
Total Long-Term Assets | 1.1B +0.44% | 1.1B -4.91% | 1.2B +2.66% | 1.1B +5.58% | |
Total Assets | 23.1B +8.08% | 21.4B -0.61% | 21.5B +2.05% | 21.1B -10.19% | |
Income Taxes Payable | 244.1M -30.75% | 352.5M -49.10% | 692.5M -25.90% | 934.5M -28.88% | |
Total Short-Term Debt | 587.1M -31.97% | 863.0M -4.11% | 900.0M +65.35% | 544.3M -66.09% | |
Total Current Liabilities | 2.6B +5.42% | 2.5B -14.23% | 2.9B +21.17% | 2.4B -32.00% | |
Total Long-Term Debt | 6.9B +29.77% | 5.3B +9.73% | 4.9B -5.52% | 5.2B -5.70% | |
Total Long-Term Liabilities | 626.1M -15.86% | 744.1M +14.11% | 652.1M +3.08% | 632.6M +3.77% | |
Total Liabilities | 10.4B +16.84% | 8.9B -1.33% | 9.0B -0.34% | 9.0B -16.23% | |
Retained Earnings | 11.6B +4.65% | 11.1B +6.84% | 10.4B +8.63% | 9.6B -7.12% | |
Total Stockholders Equity | 12.7B +1.84% | 12.5B -0.10% | 12.5B +3.83% | 12.0B -5.06% | |
Total Shares Outstanding | 318.7M +0.38% | 317.5M +0.41% | 316.2M +0.76% | 313.8M +0.32% | |
Cash Flow | |||||
Cash from Operating Activities | 1.7B +13.19% | 1.5B -5.20% | 1.6B +23.11% | 1.3B -14.31% | |
Capital Expenditures | 224.5M +10.16% | 203.8M -29.99% | 291.1M +54.92% | 187.9M +9.24% | |
Cash from Investing Activities | -2.0B +122.46% | -888.1M +14.02% | -778.9M +47.18% | -529.2M +5.08% | |
Dividends Paid | 190.3M -2.91% | 196.0M -2.44% | 200.9M -0.15% | 201.2M +0.55% | |
Cash from Financing Activities | 326.0M +167.29% | -484.5M -36.54% | -763.5M -9.52% | -843.8M -35.39% | |
Financials Ratio | |||||
Gross Margin | 69.71% -2.46% | 71.46% -0.49% | 71.82% +1.30% | 70.90% +1.10% | |
Operating Margin | 13.34% -20.33% | 16.74% -3.10% | 17.28% +72.22% | 10.03% +0.79% | |
Return on Assets | 3.17% -24.78% | 4.22% -12.36% | 4.81% +362.89% | 1.04% -38.04% | |
Return on Equity | 5.60% -22.66% | 7.25% -13.32% | 8.36% +345.78% | 1.88% -41.98% | |
Revenue Growth | 7.20% +87.21% | 3.85% -41.24% | 6.55% +157.23% | -11.44% -198.98% | |
Current Ratio | 1.98 +3.97% | 1.91 +18.15% | 1.61 -14.07% | 1.88 +33.28% | |
Cash Ratio | 0.23 +6.86% | 0.21 +47.35% | 0.15 -8.66% | 0.16 +15.43% | |
Debt-to-Equity Ratio | 0.59 +19.01% | 0.50 +7.66% | 0.46 -2.47% | 0.47 -15.12% | |
Debt-to-Assets Ratio | 0.33 +12.12% | 0.29 +8.24% | 0.27 -0.78% | 0.27 -10.29% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow